Better Than Oil Stocks?
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment.
CLICK HERE TO FIND OUT MORE

NBIX Insider Trading

Insider Ownership Percentage: 4.40%
Insider Buying (Last 12 Months): $39,032,821.44
Insider Selling (Last 12 Months): $29,483,430.80

Neurocrine Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Neurocrine Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Neurocrine Biosciences Share Price & Price History

Current Price: $115.16
Price Change: Price Decrease of -0.3 (-0.26%)
As of 09/28/2023 01:00 AM ET

This chart shows the closing price history over time for NBIX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
Get the name of the company here >>>

Neurocrine Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/12/2023Gary A. LyonsDirectorSell5,000$115.02$575,100.00203,697View SEC Filing Icon  
9/1/2023Gary A. LyonsDirectorSell5,000$110.06$550,300.00203,697View SEC Filing Icon  
9/1/2023Julie CookeInsiderSell824$110.93$91,406.3217,263View SEC Filing Icon  
8/30/2023David W. BoyerInsiderSell2,733$107.60$294,070.803,460View SEC Filing Icon  
8/28/2023Ingrid DelaetInsiderSell1,431$107.52$153,861.125,931View SEC Filing Icon  
8/21/2023Jude OnyiaInsiderSell3,198$107.37$343,369.269,638View SEC Filing Icon  
8/21/2023Kevin Charles GormanCEOSell9,328$107.40$1,001,827.20499,754View SEC Filing Icon  
8/21/2023Matt AbernethyCFOSell2,132$107.39$228,955.4827,131View SEC Filing Icon  
5/1/2023Julie CookeInsiderSell11,397$103.89$1,184,034.3316,169View SEC Filing Icon  
5/1/2023William H. RastetterDirectorSell4,300$101.43$436,149.0042,785View SEC Filing Icon  
4/24/2023Eiry RobertsInsiderSell14,400$103.48$1,490,112.0026,644View SEC Filing Icon  
4/21/2023William H. RastetterDirectorSell6,034$105.04$633,811.3639,460View SEC Filing Icon  
4/19/2023William H. RastetterDirectorSell903$105.00$94,815.0034,729View SEC Filing Icon  
2/23/2023Neurocrine Biosciences IncMajor ShareholderBuy4,395,588$8.88$39,032,821.448,575,316View SEC Filing Icon  
2/8/2023Eric BenevichInsiderSell980$104.12$102,037.6034,381View SEC Filing Icon  
2/8/2023Kevin Charles GormanCEOSell2,274$104.30$237,178.20491,365View SEC Filing Icon  
2/7/2023Matt AbernethyCFOSell26,328$102.40$2,695,987.2024,333View SEC Filing Icon  
2/6/2023Eric BenevichInsiderSell1,280$105.63$135,206.4017,879View SEC Filing Icon  
2/6/2023Kevin Charles GormanCEOSell3,040$105.68$321,267.20468,008View SEC Filing Icon  
1/31/2023Eiry RobertsInsiderSell1,457$109.99$160,255.4326,171View SEC Filing Icon  
1/31/2023Kevin Charles GormanCEOSell2,707$110.08$297,986.56465,278View SEC Filing Icon  
1/31/2023Matt AbernethyCFOSell1,283$109.98$141,104.3421,357View SEC Filing Icon  
1/6/2023Eric BenevichInsiderSell400$125.00$50,000.0015,643View SEC Filing Icon  
1/3/2023Stephen A. SherwinDirectorSell30,000$118.86$3,565,800.0025,055View SEC Filing Icon  
11/30/2022Eric BenevichInsiderSell50,000$125.90$6,295,000.0015,643View SEC Filing Icon  
11/10/2022Eric BenevichInsiderSell100$125.36$12,536.0015,643View SEC Filing Icon  
11/8/2022Eric BenevichInsiderSell24,593$125.33$3,082,240.6915,643View SEC Filing Icon  
11/3/2022Darin LippoldtInsiderSell4,518$125.02$564,840.3629,234View SEC Filing Icon  
11/1/2022Darin LippoldtInsiderSell10,000$120.09$1,200,900.0029,234View SEC Filing Icon  
10/31/2022Gary A. LyonsDirectorSell15,000$114.76$1,721,400.00203,697View SEC Filing Icon  
10/27/2022Darin LippoldtInsiderSell4,923$115.04$566,341.9229,234View SEC Filing Icon  
10/17/2022Eric BenevichInsiderSell4,960$110.82$549,667.2015,643View SEC Filing Icon  
10/4/2022Gary A. LyonsDirectorSell5,000$110.54$552,700.00203,697View SEC Filing Icon  
10/3/2022David W. BoyerInsiderSell1,437$106.59$153,169.834,214View SEC Filing Icon  
8/12/2022Malcolm Lloyd-SmithInsiderSell21,533$105.95$2,281,421.3518,888View SEC Filing Icon  
6/27/2022Julie CookeInsiderSell754$100.00$75,400.0016,918View SEC Filing Icon  
5/9/2022Richard F. PopsDirectorSell15,000$76.30$1,144,500.0029,512View SEC Filing Icon  
4/25/2022Gary A. LyonsDirectorSell15,000$92.76$1,391,400.00208,697View SEC Filing Icon  
4/1/2022William H. RastetterDirectorSell10,728$94.93$1,018,409.0434,022View SEC Filing Icon  
3/22/2022Darin LippoldtInsiderSell8,455$95.05$803,647.75View SEC Filing Icon  
3/18/2022Darin LippoldtInsiderSell300$95.00$28,500.00View SEC Filing Icon  
2/7/2022David W. BoyerInsiderSell240$81.07$19,456.80View SEC Filing Icon  
2/7/2022Kevin Charles GormanCEOSell8,710$80.82$703,942.20View SEC Filing Icon  
2/7/2022Matt AbernethyCFOSell3,310$80.79$267,414.90View SEC Filing Icon  
1/24/2022Stephen A. SherwinDirectorSell15,000$74.43$1,116,450.00View SEC Filing Icon  
1/10/2022Eiry RobertsInsiderSell2,632$74.50$196,084.00View SEC Filing Icon  
1/5/2022Kyle GanoInsiderSell28,266$85.50$2,416,743.00View SEC Filing Icon  
12/1/2021Matt AbernethyCFOSell1,645$82.59$135,860.55View SEC Filing Icon  
10/7/2021Dimitri E. GrigoriadisInsiderSell8,000$104.81$838,480.00View SEC Filing Icon  
10/7/2021Gary A. LyonsDirectorSell5,000$105.06$525,300.00View SEC Filing Icon  
10/4/2021Julie CookeInsiderSell987$101.73$100,407.51View SEC Filing Icon  
8/16/2021Eric BenevichInsiderSell5,628$89.62$504,381.36View SEC Filing Icon  
7/27/2021Malcolm Lloyd-SmithInsiderSell16,709$93.80$1,567,304.2015,801View SEC Filing Icon  
6/10/2021Gary A. LyonsDirectorSell10,000$100.27$1,002,700.00View SEC Filing Icon  
2/10/2021Malcolm Lloyd-SmithInsiderSell1,700$119.96$203,932.0033,610View SEC Filing Icon  
2/8/2021Eiry RobertsInsiderSell2,363$116.78$275,951.1417,231View SEC Filing Icon  
2/8/2021Kevin Charles GormanCEOSell10,466$116.75$1,221,905.50443,249View SEC Filing Icon  
2/8/2021Matt AbernethyCFOSell2,910$116.82$339,946.2013,043View SEC Filing Icon  
2/5/2021Kevin Charles GormanCEOSell2,422$114.16$276,495.52443,249View SEC Filing Icon  
2/5/2021Malcolm Lloyd-SmithInsiderSell865$114.15$98,739.7529,675View SEC Filing Icon  
1/26/2021Malcolm Lloyd-SmithInsiderSell1,100$119.97$131,967.0033,013View SEC Filing Icon  
1/25/2021Gary A. LyonsDirectorSell1,600$120.03$192,048.00View SEC Filing Icon  
1/8/2021Eiry RobertsInsiderSell2,632$111.06$292,309.9215,845View SEC Filing Icon  
1/8/2021Kevin Charles GormanCEOSell308,250$110.22$33,975,315.00584,520View SEC Filing Icon  
12/1/2020Matt AbernethyCFOSell1,645$94.66$155,715.7011,494View SEC Filing Icon  
11/12/2020Eric BenevichInsiderSell2,257$90.71$204,732.4717,405View SEC Filing Icon  
11/12/2020Kevin Charles GormanCEOSell3,390$90.78$307,744.20441,071View SEC Filing Icon  
11/2/2020Eric BenevichInsiderSell20,595$96.53$1,988,035.3535,969View SEC Filing Icon  
10/2/2020Julie CookeInsiderSell987$95.26$94,021.629,549View SEC Filing Icon  
See Full Table
Holding NVDA? Read This Now
NVDA is likely not the best buy for A.I. investors. 50-year Wall Street veteran Marc Chaikin reveals what to buy instead. Learn more here.
Learn more here.

SEC Filings (Institutional Ownership Changes) for Neurocrine Biosciences (NASDAQ:NBIX)

93.54% of Neurocrine Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NBIX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Neurocrine Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/24/2023Alberta Investment Management Corp82,795$7.81M0.1%+10.4%0.085%Search for SEC Filing on Google Icon
8/22/2023Virginia Retirement Systems ET AL144,023$13.58M0.1%N/A0.147%Search for SEC Filing on Google Icon
8/22/2023Comerica Bank18,144$17.11M0.0%N/A0.019%Search for SEC Filing on Google Icon
8/21/2023BOKF NA4,438$0.42M0.0%-5.4%0.005%Search for SEC Filing on Google Icon
8/21/2023California State Teachers Retirement System152,689$14.40M0.0%-3.0%0.156%Search for SEC Filing on Google Icon
8/21/2023Teachers Retirement System of The State of Kentucky49,943$4.71M0.0%+6.9%0.051%Search for SEC Filing on Google Icon
8/17/2023Orion Portfolio Solutions LLC28,211$2.66M0.0%-11.2%0.029%Search for SEC Filing on Google Icon
8/16/2023Nuveen Asset Management LLC324,174$30.57M0.0%+33.0%0.332%Search for SEC Filing on Google Icon
8/15/2023Alliancebernstein L.P.138,083$13.02M0.0%-8.8%0.141%Search for SEC Filing on Google Icon
8/15/2023Public Employees Retirement System of Ohio43,830$4.13M0.0%-8.0%0.045%Search for SEC Filing on Google Icon
8/15/2023Blueshift Asset Management LLC4,481$0.42M0.2%N/A0.005%Search for SEC Filing on Google Icon
8/15/2023Natixis Advisors L.P.24,770$2.34M0.0%-54.3%0.025%Search for SEC Filing on Google Icon
8/15/2023Vestcor Inc17,241$1.63M0.1%+28.3%0.018%Search for SEC Filing on Google Icon
8/15/2023Woodline Partners LP1,152,189$108.65M1.3%+189.0%1.180%Search for SEC Filing on Google Icon
8/15/2023XTX Topco Ltd8,508$0.80M0.1%+92.1%0.009%Search for SEC Filing on Google Icon
8/15/2023Y Intercept Hong Kong Ltd3,937$0.37M0.0%-36.7%0.004%Search for SEC Filing on Google Icon
8/15/2023Zimmer Partners LP18,200$1.72M0.0%N/A0.019%Search for SEC Filing on Google Icon
8/15/2023Goldman Sachs Group Inc.824,637$77.76M0.0%-15.0%0.844%Search for SEC Filing on Google Icon
8/15/2023Captrust Financial Advisors2,983$0.28M0.0%+3.5%0.003%Search for SEC Filing on Google Icon
8/15/2023Lazard Asset Management LLC1,860$0.18M0.0%-95.9%0.002%Search for SEC Filing on Google Icon
8/15/2023Point72 Asset Management L.P.111,358$10.50M0.0%N/A0.114%Search for SEC Filing on Google Icon
8/15/2023Rockefeller Capital Management L.P.6,945$0.66M0.0%+3.3%0.007%Search for SEC Filing on Google Icon
8/15/2023Scout Investments Inc.351,947$35.33M0.7%+170.0%0.360%Search for SEC Filing on Google Icon
8/15/2023Seven Eight Capital LP6,430$0.61M0.1%N/A0.007%Search for SEC Filing on Google Icon
8/15/2023Stifel Financial Corp14,992$1.41M0.0%-3.8%0.015%Search for SEC Filing on Google Icon
8/15/2023Hudson Bay Capital Management LP77,500$7.31M0.1%+158.3%0.079%Search for SEC Filing on Google Icon
8/15/2023Kennedy Capital Management LLC56,665$5.34M0.1%+21.5%0.058%Search for SEC Filing on Google Icon
8/15/2023Braidwell LP933,362$88.02M2.9%+21.7%0.956%Search for SEC Filing on Google Icon
8/15/2023Cantor Fitzgerald L. P.95,334$8.99M0.2%-0.1%0.098%Search for SEC Filing on Google Icon
8/14/2023PDT Partners LLC10,512$0.99M0.1%N/A0.011%Search for SEC Filing on Google Icon
8/14/2023Caisse DE Depot ET Placement DU Quebec168,669$15.91M0.0%-50.7%0.173%Search for SEC Filing on Google Icon
8/14/2023Mercer Global Advisors Inc. ADV3,375$0.32M0.0%+3.7%0.003%Search for SEC Filing on Google Icon
8/14/2023Orion Portfolio Solutions LLC28,211$15.27M0.2%-11.2%0.029%Search for SEC Filing on Google Icon
8/14/2023Aurora Investment Counsel13,508$1.27M0.8%-1.1%0.014%Search for SEC Filing on Google Icon
8/14/2023Tower Research Capital LLC TRC 12,003$1.13M0.0%+101.4%0.012%Search for SEC Filing on Google Icon
8/14/2023Two Sigma Securities LLC4,839$0.46M0.0%+10.5%0.005%Search for SEC Filing on Google Icon
8/14/2023Schonfeld Strategic Advisors LLC41,904$3.95M0.0%-55.5%0.043%Search for SEC Filing on Google Icon
8/14/2023State of Wisconsin Investment Board61,280$5.78M0.0%-0.3%0.063%Search for SEC Filing on Google Icon
8/14/2023State Street Corp3,956,499$373.10M0.0%+4.1%4.052%Search for SEC Filing on Google Icon
8/14/2023Bellevue Group AG2,612,800$246.39M3.5%0.0%2.676%Search for SEC Filing on Google Icon
8/14/2023MML Investors Services LLC5,958$0.56M0.0%-13.8%0.006%Search for SEC Filing on Google Icon
8/14/2023UniSuper Management Pty Ltd103,593$9.77M0.1%N/A0.106%Search for SEC Filing on Google Icon
8/14/2023American Trust3,800$0.36M0.0%-3.1%0.004%Search for SEC Filing on Google Icon
8/14/2023Treasurer of the State of North Carolina69,088$6.52M0.0%+0.6%0.071%Search for SEC Filing on Google Icon
8/14/2023WINTON GROUP Ltd2,534$0.24M0.0%-94.0%0.003%Search for SEC Filing on Google Icon
8/14/2023Snowden Capital Advisors LLC10,124$0.96M0.0%+106.7%0.010%Search for SEC Filing on Google Icon
8/14/2023Nuveen Asset Management LLC324,174$30.57M0.0%+33.0%0.332%Search for SEC Filing on Google Icon
8/14/2023Prosight Management LP170,000$16.03M4.9%+112.5%0.174%Search for SEC Filing on Google Icon
8/14/2023Driehaus Capital Management LLC127,353$12.01M0.2%-33.8%0.130%Search for SEC Filing on Google Icon
8/14/2023Polar Capital Holdings Plc375,000$35.36M0.2%N/A0.384%Search for SEC Filing on Google Icon
8/14/2023Thrivent Financial for Lutherans25,185$2.38M0.0%-1.2%0.026%Search for SEC Filing on Google Icon
8/14/2023Cerity Partners LLC4,214$0.40M0.0%+9.5%0.004%Search for SEC Filing on Google Icon
8/11/2023BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp8,789$0.83M0.0%+2.7%0.009%Search for SEC Filing on Google Icon
8/11/2023Lisanti Capital Growth LLC13,590$1.28M0.2%N/A0.014%Search for SEC Filing on Google Icon
8/11/2023Pinebridge Investments L.P.26,073$2.46M0.0%+234.9%0.027%Search for SEC Filing on Google Icon
8/11/2023Renaissance Technologies LLC1,643,402$154.97M0.2%-15.6%1.683%Search for SEC Filing on Google Icon
8/11/2023Ossiam3,183$0.30M0.0%+136.0%0.003%Search for SEC Filing on Google Icon
8/11/2023Natixis22,426$2.12M0.0%+36.5%0.023%Search for SEC Filing on Google Icon
8/11/2023Baird Financial Group Inc.26,244$2.48M0.0%+109.4%0.027%Search for SEC Filing on Google Icon
8/11/2023Credit Suisse AG240,484$22.68M0.0%-9.4%0.246%Search for SEC Filing on Google Icon
8/11/2023BlackRock Inc.13,482,142$1.27B0.0%+0.1%13.807%Search for SEC Filing on Google Icon
8/11/2023Ameritas Investment Partners Inc.24,367$2.30M0.1%-0.9%0.025%Search for SEC Filing on Google Icon
8/11/2023Panagora Asset Management Inc.16,055$1.51M0.0%+49.1%0.016%Search for SEC Filing on Google Icon
8/11/2023Sectoral Asset Management Inc.3,460$0.33M0.1%+23.6%0.004%Search for SEC Filing on Google Icon
8/11/2023iSAM Funds UK Ltd4,745$0.45M0.4%N/A0.005%Search for SEC Filing on Google Icon
8/11/2023L2 Asset Management LLC15,625$1.47M0.7%N/A0.016%Search for SEC Filing on Google Icon
8/11/2023Bridgewater Associates LP55,165$5.20M0.0%-6.8%0.056%Search for SEC Filing on Google Icon
8/11/2023State Board of Administration of Florida Retirement System107,047$10.10M0.0%-2.2%0.110%Search for SEC Filing on Google Icon
8/11/2023The Manufacturers Life Insurance Company 94,540$8.92M0.0%-3.8%0.097%Search for SEC Filing on Google Icon
8/11/2023Hsbc Holdings PLC76,969$7.26M0.0%-33.0%0.079%Search for SEC Filing on Google Icon
8/11/2023Clearbridge Investments LLC311,997$29.42M0.0%+24.4%0.320%Search for SEC Filing on Google Icon
8/11/2023Schroder Investment Management Group63,293$5.97M0.0%+13.3%0.065%Search for SEC Filing on Google Icon
8/11/2023Guggenheim Capital LLC44,296$4.18M0.0%+5.8%0.045%Search for SEC Filing on Google Icon
8/11/2023Geode Capital Management LLC1,523,408$143.43M0.0%+6.1%1.560%Search for SEC Filing on Google Icon
8/11/2023Twin Tree Management LP5,177$0.49M0.0%N/A0.005%Search for SEC Filing on Google Icon
8/11/2023Sei Investments Co.90,589$8.54M0.0%+7.6%0.093%Search for SEC Filing on Google Icon
8/11/2023Covestor Ltd1,646$0.16M0.1%+119.2%0.002%Search for SEC Filing on Google Icon
8/11/2023Korea Investment CORP15,381$1.45M0.0%-7.0%0.016%Search for SEC Filing on Google Icon
8/11/2023E Fund Management Co. Ltd.4,783$0.45M0.0%+18.7%0.005%Search for SEC Filing on Google Icon
8/11/2023Rhenman & Partners Asset Management AB40,000$3.77M0.4%-42.9%0.041%Search for SEC Filing on Google Icon
8/11/2023DSM Capital Partners LLC1,060,270$99.98M1.6%-15.8%1.086%Search for SEC Filing on Google Icon
8/11/2023PNC Financial Services Group Inc.3,714$0.35M0.0%-13.1%0.004%Search for SEC Filing on Google Icon
8/11/2023Northern Trust Corp848,212$79.99M0.0%-3.1%0.869%Search for SEC Filing on Google Icon
8/11/2023ExodusPoint Capital Management LP116,705$11.01M0.1%-32.9%0.120%Search for SEC Filing on Google Icon
8/10/2023MetLife Investment Management LLC62,480$5.89M0.0%-0.9%0.064%Search for SEC Filing on Google Icon
8/10/2023Bessemer Group Inc.1,614$0.15M0.0%+8.8%0.002%Search for SEC Filing on Google Icon
8/10/2023Great West Life Assurance Co. Can97,610$9.23M0.0%-1.3%0.100%Search for SEC Filing on Google Icon
8/10/2023ProShare Advisors LLC12,013$1.13M0.0%-3.4%0.012%Search for SEC Filing on Google Icon
8/10/2023Profund Advisors LLC18,854$1.78M0.1%+16.3%0.019%Search for SEC Filing on Google Icon
8/10/2023Edgestream Partners L.P.12,703$1.20M0.1%-65.9%0.013%Search for SEC Filing on Google Icon
8/10/2023Commonwealth Equity Services LLC15,104$1.42M0.0%-1.5%0.015%Search for SEC Filing on Google Icon
8/10/2023Mirae Asset Global Investments Co. Ltd.35,564$3.36M0.0%-9.5%0.036%Search for SEC Filing on Google Icon
8/10/2023Shelton Capital Management4,761$0.45M0.0%-2.8%0.005%Search for SEC Filing on Google Icon
8/10/2023Great Lakes Advisors LLC40,365$3.81M0.0%-51.8%0.041%Search for SEC Filing on Google Icon
8/10/2023Quadrant Capital Group LLC1,232$0.12M0.0%+49.0%0.001%Search for SEC Filing on Google Icon
8/10/2023Russell Investments Group Ltd.400,364$37.76M0.1%+16.8%0.410%Search for SEC Filing on Google Icon
8/10/2023Jupiter Asset Management Ltd.327,792$30.89M0.3%+5.8%0.336%Search for SEC Filing on Google Icon
8/10/2023Westpac Banking Corp2,268$0.21M0.0%-68.0%0.002%Search for SEC Filing on Google Icon
8/10/2023Cetera Advisor Networks LLC4,257$0.40M0.0%+64.2%0.004%Search for SEC Filing on Google Icon
8/10/2023Charles Schwab Investment Management Inc.604,933$57.05M0.0%+3.5%0.619%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Neurocrine Biosciences logo
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its products include INGREZZA and DYSVAL, for the treatment of tardive dyskinesia. The company's commercial products include ONGENTYS, used as an adjunctive therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women, as well as ALKINDI SPRINKLE, for the treatment of pediatric adrenal insufficiency. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; and NBI-827104 to treat rare pediatric epilepsy and essential tremor. The company's products in clinical development also comprise NBI-1065845 for the treatment of major depressive disorder; NBI-1065846 for treating anhedonia in major depressive disorder; and NBI-1117568 for the treatment of schizophrenia. It has license and collaboration agreements with Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; Sentia Medical Sciences Inc.; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.
Read More on Neurocrine Biosciences

Today's Range

Now: $115.16
Low: $113.70
High: $115.39

50 Day Range

MA: $107.67
Low: $98.79
High: $117.10

52 Week Range

Now: $115.16
Low: $89.04
High: $129.29

Volume

490,486 shs

Average Volume

759,396 shs

Market Capitalization

$11.25 billion

P/E Ratio

66.57

Dividend Yield

N/A

Beta

0.46

Who are the company insiders with the largest holdings of Neurocrine Biosciences?

Neurocrine Biosciences' top insider shareholders include:
  1. Neurocrine Biosciences Inc (Major Shareholder)
  2. Kevin Charles Gorman (CEO)
  3. Gary A Lyons (Director)
  4. William H Rastetter (Director)
  5. Eric Benevich (Insider)
  6. Richard F Pops (Director)
  7. Darin Lippoldt (Insider)
  8. Matt Abernethy (CFO)
  9. Eiry Roberts (Insider)
  10. Stephen A Sherwin (Director)
  11. Malcolm Lloyd-Smith (Insider)
  12. Julie Cooke (Insider)
  13. Jude Onyia (Insider)
  14. Ingrid Delaet (Insider)
  15. David W Boyer (Insider)
  16. Dimitri E Grigoriadis (Insider)
  17. Kyle Gano (Insider)
Learn More about top insider investors at Neurocrine Biosciences.

Who are the major institutional investors of Neurocrine Biosciences?

Neurocrine Biosciences' top institutional investors include:
  1. BlackRock Inc. — 13.81%
  2. State Street Corp — 4.05%
  3. Bellevue Group AG — 2.68%
  4. Renaissance Technologies LLC — 1.68%
  5. Bank of New York Mellon Corp — 1.63%
  6. Geode Capital Management LLC — 1.56%
Learn More about top institutional investors of Neurocrine Biosciences stock.

Which institutional investors are selling Neurocrine Biosciences stock?

During the previous quarter, NBIX stock was sold by these institutional investors:
  1. Congress Asset Management Co. MA
  2. Envestnet Asset Management Inc.
  3. Renaissance Technologies LLC
  4. DSM Capital Partners LLC
  5. Caisse DE Depot ET Placement DU Quebec
  6. Goldman Sachs Group Inc.
  7. Bank of Nova Scotia
  8. Los Angeles Capital Management LLC
During the previous year, company insiders that have sold Neurocrine Biosciences company stock include:
  1. Neurocrine Biosciences Inc (Major Shareholder)
  2. Kevin Charles Gorman (CEO)
  3. Gary A Lyons (Director)
  4. William H Rastetter (Director)
  5. Eric Benevich (Insider)
  6. Richard F Pops (Director)
  7. Darin Lippoldt (Insider)
  8. Matt Abernethy (CFO)
  9. Eiry Roberts (Insider)
  10. Stephen A Sherwin (Director)
  11. Malcolm Lloyd-Smith (Insider)
  12. Julie Cooke (Insider)
Learn More investors selling Neurocrine Biosciences stock.

Which institutional investors are buying Neurocrine Biosciences stock?

Within the previous quarter, NBIX stock was bought by institutional investors including:
  1. Woodline Partners LP
  2. Ieq Capital LLC
  3. Polar Capital Holdings Plc
  4. Bank of Montreal Can
  5. Scout Investments Inc.
  6. Iron Triangle Partners LP
  7. Assenagon Asset Management S.A.
  8. Braidwell LP
Better Than Oil Stocks?
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment.
CLICK HERE TO FIND OUT MORE